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ABSTRACT
Bisulfite treatment can be used to ascertain
the methylation states of individual cytosines in
DNA. Ideally, bisulfite treatment deaminates
unmethylated cytosines to uracils, and leaves
5-methylcytosines unchanged. Two types of
bisulfite-conversion error occur: inappropriate
conversion of 5-methylcytosine to thymine, and
failure to convert unmethylated cytosine to uracil.
Conventional bisulfite treatment requires hours of
exposure to low-molarity, low-temperature bisulfite
(‘LowMT’) and, sometimes, thermal denaturation.
An alternate, high-molarity, high-temperature
(‘HighMT’) protocol has been reported to accelerate
conversion and to reduce inappropriate conversion.
We used molecular encoding to obtain validated,
individual-molecule data on failed- and inappropri-
ate-conversion frequencies for LowMT and HighMT
treatments of both single-stranded and hairpin-
linked oligonucleotides. After accounting for
bisulfite-independent error, we found that: (i) inap-
propriate-conversion events accrue predominantly
on molecules exposed to bisulfite after they have
attained complete or near-complete conversion; (ii)
the HighMT treatment is preferable because it yields
greater homogeneity among sites and among
molecules in conversion rates, and thus yields
more reliable data; (iii) different durations of bisulfite
treatment will yield data appropriate to address
different experimental questions; and (iv) conversion
errors can be used to assess the validity of methyla-
tion data collected without the benefit of
molecular encoding.
INTRODUCTION
Analysis of methylation states in genomic DNA has pro-
vided insights into biological phenomena as disparate as
genomic imprinting (1,2), human disease (3,4) and atypical
ﬂoral morphologies (5,6). In eukaryotic genomes, DNA
methylation usually involves addition of a methyl group
to the 5-carbon of cytosine, yielding 5-methylcytosine.
Because both cytosine and 5-methylcytosine are comple-
mentary to guanine, conventional sequencing does not
distinguish between them. Of the various methods typi-
cally used to assess DNA methylation states, only one—
bisulﬁte treatment of genomic DNA, followed by PCR
ampliﬁcation, cloning and sequencing of individual PCR
amplimers (7)—yields information on the methylation
states of individual cytosines on individual DNA mole-
cules. This detailed information is essential to address
many questions in epigenetics (8–10).
Bisulﬁte treatment is expected to deaminate cytosine
to uracil (Figure 1a), and to leave 5-methylcytosine
unchanged (11,12) (Figure 1b). When bisulﬁte-treated
DNA is ampliﬁed by PCR, 5-methylcytosine on the tem-
plate strand pairs with guanine on the newly synthesized
strand; converted cytosine, which is uracil, pairs with ade-
nine. The methylation patterns of individual DNA mole-
cules therefore can be inferred from the sequences of
subcloned PCR products (12). A cytosine site is inter-
preted as having been unmethylated if it is occupied by
thymine and as having been methylated if it is occupied
by cytosine.
The most reliable analyses of data from bisulﬁte-treated
DNA are those that account for both types of conversion
error: failed conversion and inappropriate conversion.
The better studied of these errors—failed conversion—is
said to occur when an unmethylated cytosine fails to be
deaminated, and thus appears in resulting data as if it had
been methylated (Figure 1a). Because 5-methylcytosine
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exclusively at CpG cytosines (13), the failed-conversion
frequency for bisulﬁte treatment of mammalian DNA
is indicated by the fraction of non-CpG cytosines that
appear as cytosines in sequence data. When not explicitly
incorporated as a parameter in data analysis, failed con-
version can inﬂate estimates of methylation densities, and
can undermine eﬀorts to determine the sequence motif
preferences of DNA methyltransferases. The failed-
conversion frequency can typically be reduced by increas-
ing the duration of bisulﬁte treatment (14), by increasing
the number of thermal denaturation steps used during
conversion (9,15), or both.
A second type of error—inappropriate conversion—is
said to occur when a methylated cytosine is deaminated,
yielding thymine (Figure 1b) (14,16). Like uracils that
result from deamination of cytosines, thymines that arise
through inappropriate conversion of 5-methylcytosine
will pair with adenine during PCR. As a result,
5-methylcytosines that undergo inappropriate conversion
will be misinterpreted as unmethylated. When inappropri-
ate conversion occurs and is ignored in data analysis,
it will lead to underestimates of genomic methylation
densities. In contrast, when inappropriate conversion
occurs and its frequency is known, it can be included as
a parameter in the data analysis. Information on failed-
and inappropriate-conversion frequencies is therefore
essential for inference from detailed DNA methylation
patterns.
Two previous studies have explicitly investigated failed-
and inappropriate-conversion frequencies under the con-
ventional bisulﬁte-conversion protocol, which uses 5.5M
bisulﬁte and 558C. We term these conditions ‘LowMT’
(low molarity/temperature). Grunau et al. (14) treated
enzymatically methylated DNA under LowMT condi-
tions, and reported inappropriate-conversion frequencies
that may be as high as 6%. Shiraishi and Hayatsu (16)
reported a comparable inappropriate-conversion fre-
quency under similar conditions for conversion of
DNA from a densely methylated tumor cell line. Neither
analysis was able explicitly to exclude alternate explana-
tions for these events. Bisulﬁte-independent phenomena,
including incomplete methylation in cancer cell lines,
incomplete enzymatic methylation of synthetic DNA,
and errors during PCR ampliﬁcation of bisulﬁte-
converted DNA, could, potentially, mimic conversion
errors and lead to overestimates of inappropriate-
conversion frequencies.
Shiraishi and Hayatsu (16) also introduced an alter-
native to the LowMT bisulﬁte-conversion protocol.
They reported that applying high-molarity (9M), high-
temperature (708C) bisulﬁte treatment of much shorter
duration—a protocol that we here term ‘HighMT’
(high molarity/temperature) (16,17)—decreases the time
required for conversion, and may reduce inappropriate-
conversion frequencies without appreciable increases
in failed-conversion frequencies. Despite the potential
advantages of the HighMT treatment over the conven-
tional, LowMT protocol, its conversion dynamics
remain largely unexplored. A few papers have cited the
original work of Shiraishi and Hayatsu (16), but only
one study (18) provides data from DNA converted
under HighMT conditions. No published study has pro-
vided a comprehensive analysis of conversion errors under
HighMT conditions.
We investigated conversion error with the goal of
understanding how its dynamics can inform the design
of bisulﬁte treatment protocols and the interpretation of
resulting data. We treated methylated, synthetic oligo-
nucleotides under the LowMT and HighMT treatments,
and compiled failed- and inappropriate-conversion counts
for individual molecules sampled after various durations
of bisulﬁte treatment. Unlike genomic DNAs, whose
apparent methylation patterns represent the combined
consequences of biological variability and experimental
error, oligonucleotides have methylation patterns that
can be synthetically speciﬁed, and experimentally con-
ﬁrmed. Using synthetic oligonucleotides therefore allowed
us to eliminate variation due to biological phenomena,
and to conduct a more direct investigation of conversion
error than would be feasible with genomic DNAs.
We obtained data from single-stranded oligonucleo-
tides, as well as from hairpin-linked oligonucleotides
that provide information on both the top and bottom
strands of individual DNA molecules. We validated our
data by using molecular batchstamps and barcodes (19,
Burden et al., manuscript in preparation) to distinguish
valid from contaminant and redundant sequences, and
by measuring the frequencies of several processes that
could mimic inappropriate conversion.
Here, we address ﬁve speciﬁc questions:
(i) Is there evidence for inappropriate conversion
under both the HighMT and LowMT treatments,
even in analyses that control for bisulﬁte-
independent error?
(ii) Do inappropriate-conversion events occur through-
out the conversion process, or do they occur
(a)
(b)
Figure 1. Responses of methylated and unmethylated cytosines to
bisulﬁte treatment. (a) Unmethylated cytosines treated with bisulﬁte
are either converted to uracil, or fail to be converted and remain as
cytosine. (b) the 5-methylcytosines treated with bisulﬁte either do not
undergo conversion, or are inappropriately converted to thymine.
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converted?
(iii) Is either the LowMT or the HighMT protocol
generally preferable?
(iv) How can knowledge of frequencies for both
inappropriate- and failed-conversion inform the
design of treatment protocols?
(v) Under what circumstances are conversion errors
useful?
METHODS
Designandassemblyofmolecularlyencodedoligonucleotides
Design and assembly of double-stranded oligonucleotides.
To build a DNA substrate with which to measure
conversion-error frequencies, we designed and ordered
from GeneLink, Hawthorne, NY (http://www.genelink.
com/) four single-stranded synthetic oligonucleotides.
Two of these, methylated top strand (‘TM’) and methyl-
ated bottom strand (‘BM’), contained 5-methylcytosine at
all 10 of their CpG sites.
The sequences of the oligonucleotides were based on a
region of the human FMR1 promoter.
TM was 139 nucleotides long and had sequence:
50-Phos CATGTCCACTTGAAGAGAGAGGGXGGG
GCXGAGGGGCTGAGCCXGXGGGGGGAGGGAA
CAGXGTTGAT...
CAXGTGAXGTGGTTTCAGTGTTTACACCXGCAG
XGGGCXGCCCAACAAATTCACGAACCGATGGG
ATATGT 30.
BM was 125 nucleotides long and had sequence:
50 ATCGGTTCGTGAATTTGTTGGGXGGCCXGC
TGXGGGTGTAAACACTGAAACCAXGTCAXGTG
ATC...
AAXGCTGTTCCCTCCCCCXGXGGGCTCAGCCCC
TXGGCCCXGCCCTCTCTCTTCAAGTGG 30.
In the sequences above, ‘X’ indicates a methylated CpG
cytosine.
The other two oligonucleotides, (‘TU’), unmethylated
top strand, and (‘BU’), unmethylated bottom strand,
were identical in sequence to TM and BM, except that
they contained cytosines at the sites that were occupied
by 5-methylcytosine in TM and BM.
To assemble double-stranded molecules from one
version of the top strand oligonucleotide (TM or TU)
and one version of the bottom strand oligonucleotide
(BM or BU), 1.65ml of 500mM solutions of each strand
were combined in 30ml of Buﬀer EB (Qiagen, Valencia,
CA), heated to 858C for 3min, and then cooled to room
temperature. The annealed, double-stranded oligonucleo-
tide was designed to basepair at 125nt, with the top strand
overhanging the bottom strand by 5nt at the 50-end, and
by 9nt at the 30 end.
Molecular encoding with hairpin linkers. Hairpin linkers
were covalently linked to the TM:BM oligonucleotide
using the protocol previously described (19). Hairpin
linkers contained a batchstamp that was unique to each
experiment, thus enabling us to detect contamination, and
a random barcode, thus enabling us to detect sequence
redundancy (Figure 2).
A second conﬁguration of hairpin oligonucleotides was
used for an experiment to evaluate the frequency of failed-
conversion with bisulﬁte solutions used soon after opening
compared with those used 22 months after opening, and to
evaluate the possible impact of complementary strands
on the frequency of conversion error. For this experiment,
TU was annealed to a complementary oligonucleotide that
was ordered as a truncated version of BU. This shorter
bottom strand contained the last 53nt of the BU sequence
depicted above. Annealing of truncated BU to TU thus
yielded a complex that contained 53 complementary bases,
with a 5-nt overhang at the 50 end and an 81-nt overhang
at the 30-end. Hairpin ligation of this complex produced a
molecularly encoded molecule that had appreciable num-
bers of unmethylated and methylated cytosines in both
single- and double-stranded regions.
Molecular encoding with end-codes. Oligonucleotide
molecules to be used in experiments with single-stranded
DNA were batchstamped and barcoded through covalent
attachment of an ‘end-code’ (Burden et al., manuscript
in preparation; Figure 3). Each end-code oligonucleotide
contained a deﬁned batchstamp speciﬁc to that experi-
ment, a randomly generated barcode, and a 5-nt overhang
complementary to the 50-overhang of the top strand of the
double-strandedoligonucleotide.End-coderswere combined
Figure 2. A hairpin-linked TM:BM oligonucleotide. The
5-methylcytosines are present at each of 10 CpG sites on both top,
TM, and bottom, BM, strands of TM:BM, and are indicated by
‘Me’. Each hairpin linker contains a batchstamp common to all mole-
cules processed in a given experiment, and a randomly generated
barcode (19). Hairpin-linked molecules have primer binding sites on
the top and bottom strands of the oligonucleotide, permitting subse-
quent PCR ampliﬁcation.
Figure 3. An end-coded TM oligonucleotide ligated while base-paired
with BU. The 5-methylcytosines are present at 10 CpG sites on the top
strand, TM, and are indicated with ‘Me’. The end-coder (Burden et al.,
manuscript in preparation) contains a batchstamp common to all mole-
cules processed in a given experiment, and a randomly generated bar-
code. The end-coder is attached to the top, TM, but not the bottom,
BU, strand of TM:BU. Thus, the bottom strand will separate from the
top strand under denaturating conditions. Oligonucleotides labeled with
end-coder have a forward primer binding site on TM, and a reverse-
primer binding site of 21nt, indicated here in purple, on the end-coder
itself (after Figure 1 of Burden et al., manuscript in preparation).
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ture in a 1:16.7 molar ratio, and treated with T4 ligase, as
per the manufacturer’s instructions (NEB, Ipswich, MA).
After 1 hour, the ligase was heat-inactivated at 658C for
20min. The ligation step is expected to bind the end-coder
to the top strand of the annealed oligonucleotide, using
the 50-phosphate of TM. End-coders diﬀer from hairpin
linkers in two ways: (i) they bear a reverse-primer binding
site and (ii) they lack a 50-phosphate, thus ensuring that
they attach covalently only to the top strand of TM:BU.
The end-coded top strand contains both primer binding
sites, and thus can be used to detect top-strand conversion
errors in the protocol we describe here.
Bisulfite-independent treatment of molecularly encoded
oligonucleotides
We used oligonucleotide molecules encoded with end-
codes to measure frequencies of errors that arise through
bisulﬁte-independent phenomena. We examined sequences
from molecules ampliﬁed either with no prior chemical
treatment, or after exposure to 0.3N sodium hydroxide
(NaOH) for 50min at 428C. This NaOH treatment was
designed to mimic the total NaOH exposure that mole-
cules encounter as part of the bisulﬁte conversion
protocol (20min for pre-bisulﬁte denaturation and
30min for post-bisulﬁte desulfonation).
Bisulfite treatment ofmolecularly encoded oligonucleotides
Treatment with HighMT Bisulfite. To prepare the
HighMT bisulﬁte solution (16), 2.08g of NaHSO3
(sodium bisulﬁte) and 0.67g ðNH4Þ2SO:
3H2O (ammonium
sulﬁte monohydrate) were dissolved in 5ml of 45%
NH4HSO3 in water (ammonium bisulﬁte; Spectrum
Chemical Manufacturing Corporation, Gardena, CA), to
a ﬁnal volume of 6.0ml, and pH of 5.4 and held at 708C
for 10 min.
In preparation for HighMT treatment, molecularly
encoded oligonucleotides (20ml) were ﬁrst denatured in
0.3NNaOH at 428C for 20min, added to the HighMT
bisulﬁte solution (180ml), and held at 708C for durations
ranging from 5 to 200min.
Ammonium bisulﬁte solutions change in color upon
exposure to air. They have previously been reported to
undergo spontaneous decomposition (20) during storage,
and, in particular, during prolonged exposure to oxygen.
The freshness of ammonium bisulﬁte may also impact
conversion kinetics. In one experiment, the cytosine--
conversion rate diﬀered signiﬁcantly—but by less than a
factor of 2 (data not shown)—between DNA treated with
HighMT solution prepared using a freshly opened bottle,
and DNA treated with HighMT solution that contained
ammonium bisulﬁte from a bottle that was ﬁrst opened
22 months earlier but was of the same lot number. We
recommend that ammonium bisulﬁte solutions be sam-
pled under a hood, that bottles of ammonium bisulﬁte
stocks be replaced often, and that existing stocks be
protected from air.
Treatment with LowMT Bisulfite. For the LowMT treat-
ment, molecularly encoded oligonucleotides were ﬁrst
denatured in 0.3NNaOH at 428 for 20 min. To prepare
the LowMT bisulﬁte solution, 4.05g of sodium bisulﬁte
were dissolved in 8ml of deionized water (dH2O). In a
separate tube, 50mg hydroquinone were dissolved in
25ml of dH2O. Next, 500ml of the hydroquinone solution
were combined with 230ml of 10NNaOH, and an addi-
tional 970mlo fd H 2O. For LowMT treatment of single-
stranded molecules, the 20ml DNA–NaOH solution was
combined with 180ml of the sodium bisulﬁte solution, and
held at 558C for 4–20h, with no thermal denaturation
step. Conventional treatment of hairpin-linked DNA
used the LowMT conditions, as was described previously
(15) and included 10 thermal denaturation steps.
Post-bisulfite cleanup, PCR amplification and sequencing
Bisulﬁte-treated molecules were desulfonated and puriﬁed
as described previously (15). Hairpin-linked molecules
were ampliﬁed using initiating primer 50 ...TATCCCAT
CAATTCATAAATTT...30 and reverse primer 50 ...GG
TTTGTGAATTTGTTGGG...30. Molecules encoded
with end-codes were ampliﬁed using initiating primer
50 ...TATCCCATCAATTCATAAATTT...30 and a
reverse primer corresponding to the end-coder used in
each experiment (Figure 3). We used HotStarTaq Master
Mix (Qiagen) for all ampliﬁcation reactions. PCR products
were then subcloned using the TOPO-TA cloning kit
(Invitrogen, Carlsbad, CA), and inserts from individual
colonies were ampliﬁed using T7 and M13R primers.
Colony PCR products were cycle-sequenced using either
the T7 primer or the M13R primer, and Big-Dye
Terminator v3.1 (ABI, Foster City, CA), then sequenced
on an ABI3100, using a 36cm POP6 array (Comparative
Genomics Center, University of Washington, Seattle,
WA). We used information from molecular batchstamps
and barcodes on the end-coders to exclude contaminant
and redundant sequences from each data set prior to
analysis (19, Burden et al., manuscript in preparation).
Data analysis
Calculation of point estimates and 95% intervals on
bisulfite-independent error frequencies and failed-
conversion frequencies. For those experiments that yielded
non-zero event counts in all categories, we calculated
point estimates as the number of events divided by the
number of opportunities, and calculated 95% conﬁdence
intervals under the binomial distribution.
For protocols that yielded event counts of 0 for one or
more categories, we calculated point estimates on counts
adjusted using the pseudocounts method originally pro-
posed by LaPlace (21). Under the pseudocounts method,
each observed count is treated as if it were greater by 1,
and the denominator is calculated as the true sampled
number, plus the total number of data groups. This
approach makes it possible to avoid calculating a point
estimate of 0% in cases where it is not plausible that the
true frequency is 0. For instance, even if we observed 1000
successful conversions and zero failures, this sample size
would be far too small to conclude that the true failed-
conversion frequency was 0. A more plausible explanation
would be that we had sampled too few cytosines to
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ple, LaPlace’s pseudocounts method would yield a point
estimate of (0þ1)/(1000þ2), or 0.1%.
To establish 95% credible intervals on pseudocounts-
adjusted observations, we took 10000 random draws
from a b-distribution, with a¼number of failed-
conversions and b¼number of successful conversions,
and then used the ‘quantile’ function in the freely available
statistical analysis package, R, to ﬁnd the region that
contained 95% of these random draws. In Tables 1–5,
the abbreviation ‘CI’ is used to indicate 95% conﬁdence
intervals for point estimates calculated directly, and to
indicate 95% credible intervals for point estimates calcu-
lated using pseudocounts.
Calculation of point estimates and 95% CI on
inappropriate-conversion frequencies. Apparent inappro-
priate-conversion events can result both from bisulﬁte-
independent phenomena, and from bona ﬁde conversion
errors. For each conversion protocol, we calculated the
point-estimate of the inappropriate-conversion frequency
as the apparent inappropriate-conversion frequency minus
the bisulﬁte-independent error frequency.
We compiled data on the total error, and the bisulﬁte-
independent error, and used R to calculate the 95% bino-
mial conﬁdence interval on each inappropriate-conversion
frequency estimate.
Investigating the time course of conversion for cytosine and
5-methylcytosine. We used linear regression to investigate
the time course of conversion for methylated and
unmethylated cytosines.
To examine the time course of conversion for cytosine,
we inferred the best-ﬁt line for the log10-transformed
failed-conversion counts observed for single-stranded
oligonucleotides treated under the HighMT protocol,
and for hairpin-linked oligonucleotides and plasmid
DNA, as reported by Shiraishi and Hayatsu (16). The
contribution of each mean to the regression was weighted
by the total number of cytosines examined.
To examine the time course of inappropriate conver-
sion for 5-methylcytosine, we ﬁrst inferred the best-ﬁt
line for the number of 5-methylcytosines surviving in
Table 1. Error counts in sequences derived from untreated oligonucleotides
Observed
nucleotide count
(%; 95%CI)
Expected nucleotide (n)
A (1232) T (1064) C (1120) G (2632) 5mC (560)
A 1230
(99.8%; 99.1, 99.9%)
3
(0.28%; 0.06, 0.78%)
0
(0.09%; 0.002, 0.32%)
0
(0.04%; 0.008, 0.14%)
0
(0.2%; 0.005, 0.63%)
T0
(0.08%; 0.002, 0.3%)
1057
(99.3%; 98.7, 99.7%)
10
(1%; 0.45, 1.7%)
0
(0.03%; 0.001, 0.14%)
0
(0.17%; 0.04, 0.64%)
C 0 3 1108 2 560
(0.08%; 0.002, 0.29% ) (0.28%; 0.055, 0.82%) (98.7; 98, 99.4%) (0.11%; 0.02, 0.27%) (99.4%; 98.9, 99.9%)
G 2 1 2 2630 0
(0.24%; 0.04, 0.58%) (0.09%; 0.002, 0.52%) (0.1%; 0.05, 0.66%) (0.2%; 0.004, 0.65%) (0.2%; 0.1, 0.7% )
Error counts were recorded from 56 single-stranded oligonucleotide molecules, excluding the 50-overhang and primer-binding regions. For each
molecule, we collected information from 22 adenines, 19 thymines, 20 unmethylated non-CpG cytosines, 47 guanines and 10 methylated CpG
cytosines. For columns in which one or more values were 0, percentages were calculated using the ‘pseudocounts’ method originally introduced
by LaPlace (21). Under this method, each value is treated as if it were greater by 1, and the denominator is calculated as the true value plus the total
number of groups. Values shown in parentheses below event counts for each nucleotide indicate mean error rates and 95% CI on point estimates
computed directly, or 95% credible intervals on point estimates computed using the pseudocounts method (see Methods section).
Table 2. Error counts in sequences derived from NaOH-treated oligonucleotides
Observed
nucleotide count
(%; 95%CI)
Expected nucleotide (n)
A (1320) T (1140) C (1200) G (2820) Possible 5mC (600)
A 1314 0 1 4 0
(99.2%; 98.7–99.6%) (0.08%; 0.002, 0.31%) (0.08%; 0.02–0.46%) (0.18%; 0.06–0.36%) (0.16%; 0.004, 0.61%)
T 0 1137 11 0 1
(0.07%; 0.018, 0.27) (99.8%; 99.8–99.9%) (0.92%; 0.5–1.7%) (0.03%; 0, 0.13%) (0.33%; 0.04, 0.92%)
C 3 2 1182 7 599
(0.3%; 0.08–0.7%) (0.26%; 0.05–0.65%) (98.5%; 97.6–99.1%) (0.28%; 0.12–0.5%) 99.8%; 99.4–99.9%
G 3 1 6 2809 0
(0.3%; 0.08–0.7%) (0.2%; 0.02–0.48%) (0.5%; 0.18–1.1%) (99.6%; 99.3–99.8%) (0.16%; 0.004, 0.61%)
Error counts were recorded from 60 single-stranded oligonucleotide molecules, excluding the 50 overhang and primer-binding regions. For each
molecule, we collected information from 22 adenines, 19 thymines, 20 unmethylated non-CpG cytosines, 47 guanines and 10 methylated, CpG
cytosines. See Methods section and the legend of Table 1 for information on calculation of point estimates and their CIs.
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30min, 80min and 200min of treatment with HighMT
bisulﬁte. To investigate whether inappropriate-conversion
events occurred over the entire range of treatment dura-
tions, we then excluded data from the 200-min sam-
pling point from the analysis, and asked whether there
was evidence of a signiﬁcant inverse relationship
between treatment duration and number of surviving
5-methylcytosines.
Investigating potential variation in inappropriate-
conversion frequencies across treatment protocols and
across cytosine sites. We used the Fisher’s Exact Test
for several analyses, including our comparison of the fre-
quencies of conversion error under diﬀerent treatment
protocols, and our investigation of potential site–site
variation in these frequencies. For those data sets where
sample sizes were large, we used simulated P-values to
make computation tractable.
Fisher’s Exact Test takes whole-number arguments,
so it was not feasible to use inappropriate-conversion mea-
surements that had been adjusted to account for contribu-
tions from bisulﬁte-independent error. Because we have
no evidence that bisulﬁte-independent error frequencies
vary among sites, we chose to perform the Fisher’s
Exact Test on unadjusted, raw counts of apparent
inappropriate-conversion events.
RESULTS AND DISCUSSION
Validated sequence dataconfirm that apparent
inappropriate-conversion events can arise underbisulfite
treatment ofboth single-stranded and hairpin-linked DNA
We measured the frequency of apparent inappropriate
conversion events on our methylated, synthetic oligonu-
cleotide after various bisulﬁte-treatment protocols. Our
results from LowMT and HighMT treatment of these
molecules conﬁrm prior reports that apparent inappropri-
ate-conversion events can arise at appreciable frequencies
during bisulﬁte treatment of single-stranded DNA (14,16),
and indicate that such events can also arise on hairpin-
linked molecules. Under various bisulﬁte conversion
protocols described in subsequent sections, we estimated
inappropriate-conversion frequencies to range from
0:09% to 6:1%.
Before proceeding to an analysis of these inappropriate-
conversion frequencies, we asked whether some frac-
tion of apparent-conversion events arose on our
Table 3. Error frequencies for single-stranded molecules under
HighMT treatment
Protocol Seq. % Failed conversions;
Counts (95% credible
interval)
% Inappropriate conversions;
Counts (95% credible interval)
HighMT 5min 29 63.3 0.17
349 (59.3, 67.3) 1 (0, 1.2)
HighMT 15min 39 27.4 0.089
203 (24.2, 31) 1 (0, 0.94)
HighMT 30min 29 7.4 1.2
41 (5.4, 9.8) 4 (0, 3.1)
HighMT 80min 22 0.23 0.29
0 (0, 1.3) 1 (0,1.6)
HighMT 200min 27 0.19 6.1
0 (0, 1) 17 (3.7, 9.9)
Results for each single-stranded molecule were tallied from 10 methyl-
ated, CpG cytosines and 19 unmethylated, non- CpG cytosines. The
point estimate for each error frequency is given in the ﬁrst line of each
box; the second line shows the raw event count and the 95% credible
interval on the frequency estimate (see Methods section), calculated
using the b-distribution, with distribution parameter a as the number
of conversion errors, distribution parameter b as the number of prop-
erly converted unmethylated cytosines in the case of the failed-
conversion frequency, or the number of properly non-converted
5-methylcytosines in the case of the inappropriate-conversion fre-
quency. Failed-conversion frequencies and their credible intervals
were calculated directly, except for observations of zero, for which
we used the pseudocounts correction. Inappropriate-conversion fre-
quencies were calculated as the observed percent minus the bisulﬁte-
independent error frequency.
Table 4. Error frequencies for single-stranded molecules under LowMT
bisulﬁte treatment
Protocol Seq. % Failed conversions;
Counts (95% credible
interval)
% Inappropriate conversions;
Counts (95% credible interval)
LowMT 4h 21 37.3 0.31
149 (32.7, 42.2) 1 (0, 2.5)
LowMT 8h 52 36.5 1.2
361 (33.5, 39.6) 7 (0, 2.7)
LowMT 20h 58 6.5 3.1
72 (5.1, 8.0) 19 (1.7, 4.8)
Results for each single-stranded molecule were tallied from 10 methyl-
ated, CpG cytosines and 19 unmethylated, non-CpG cytosines. The
point estimate for each error frequency is given in the ﬁrst line of
each box; the second line shows the raw event count, and the 95%
credible interval on the frequency estimate, calculated using the
b-distribution. Failed-conversion frequencies and their credible intervals
were calculated directly. Inappropriate-conversion frequencies were
calculated as the observed percent minus the bisulﬁte-independent
error frequency.
Table 5. Error frequencies for hairpin-linked molecules under HighMT
bisulﬁte treatment
Protocol Seq. % Failed conversions;
Counts (95% credible
interval)
% Inappropriate conversions;
Counts (95% credible interval)
HighMT 40 min 41 8.4 1.4
187 (7.3, 9.6) 13 (0.13, 2.7)
HighMT 60 min 12 3.2 0.67
21 (2.0, 4.7) 2 (0, 2.4)
HighMT 90 min 41 0.86 1.7
19 (0.51, 1.3) 15 (0.29, 3)
Results for each double-stranded molecule were tallied from 20 methyl-
ated, CpG cytosines and 54 unmethylated, non-CpG cytosines. The
point estimate for each error frequency is given in the ﬁrst line of
each box; the second line shows the event count, and the 95% CI on
this frequency estimate. Failed-conversion frequencies and their CI
were calculated directly. Inappropriate-conversion frequencies were
calculated as the observed percent minus the bisulﬁte-independent
error frequency, as described in Methods section.
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ena. Bisulﬁte-independent error was not considered explic-
itly in prior investigations of inappropriate-conversion
frequencies (14,16).
Bisulfite-independent errors do occur, butat <1%
of 5-methylcytosines
Errors introduced by impurities in 5-methylcytosine used
for oligonucleotide synthesis. If cytosines or thymines
were either systematically or randomly incorporated
at 5-methylcytosine positions during oligonucleotide
synthesis, they would mimic the products of inappropriate
conversion, yielding overestimates of the inappropriate-
conversion frequency.
A systematic error in the incorporation of
5-methylcytosine into our oligonucleotide would cause
all or nearly all molecules examined to contain apparent
inappropriate-conversion events at the same CpG. In the
146 single-stranded sequences examined after various
durations of HighMT treatment, no single site was
observed to have undergone apparent inappropriate
conversion more than four times. We conclude that
our oligonucleotide contains no systematic errors at
5-methylcytosine positions.
We asked whether random misincorporation of either
cytosine or thymine occurred at some 5-methylcytosine
positions. We learned from a high-performance liquid
chromatogram (HPLC) supplied by the oligonucleo-
tide manufacturer, GeneLink (www.genelink.com),
that the purity of the phosphoramidite precursor of
5-methylcytosine used to construct our synthetic oligonu-
cleotides was at least 99.8%. This purity level implies that
mistaken incorporation of cytosine could have occurred
at no >0.2% of 5-methylcytosine positions.
To further address the possibility that thymines were
incorporated at random at some 5-methylcytosine posi-
tions during oligonucleotide synthesis, we ampliﬁed,
subcloned and sequenced oligonucleotides with no prior
chemical treatment. We found that, as expected, no
thymine was present at any the 560 5-methylcytosine
positions examined in these 56 molecules (Table 1).
We conclude, using the binomial distribution, that
misincorporation of thymine occurred at <0.54% of
5-methylcytosine sites.
Errors during sequencing. DNA sequencing is a standard
component of protocols designed to collect DNA methy-
lation patterns. To investigate how often errors were
introduced during the sequencing and base-calling pro-
cesses, we performed repeat sequencing on a subset of
our clones. The T7 and M13R primers amplify molecules
subcloned with the Topo-TA Cloning Kit (Qiagen);
either primer can be used to cycle-sequence the resulting
colony amplimers. Using PCR products from each of
71 subclones, we sequenced once with M13R and once
with T7. We examined the concordance of sequences col-
lected from single clones using these two diﬀerent primers.
Sequences recovered using the T7 primer conﬁrmed
24 of the 25 apparent inappropriate-conversion
events, and 168 of the 173 apparent failed-conversion
events that we observed in sequences recovered using
the M13R primer. Thus, the vast majority (97%;
CI¼94–98.9%) of conversion errors observed in
sequences recovered using M13R were conﬁrmed by
resequencing with T7. We conclude that the vast majority
of apparent conversion errors arose by a process other
than sequencing error.
Apparent conversion errors produced by PCR. PCR
ampliﬁcation is used twice during standard bisulﬁte-
sequencing protocols: the ﬁrst PCR reaction ampliﬁes
genomic or oligonucleotide DNA immediately after bisul-
ﬁte conversion; the second prepares individual subcloned
PCR products for sequencing. Thus, all molecules exam-
ined contain information on the upper bound of the PCR
error frequency. Our above-described ﬁnding that all
560 of the 5-methylcytosine sites examined in untreated
DNA had base-paired with guanine during PCR estab-
lishes a similar upper bound on the PCR error frequency
at those sites (Table 1). We conclude that PCR error could
yield apparent inappropriate-conversion events at no
>0.54% of 5-methylcytosines.
While examining sequences derived from untreated
oligonucleotides, we noticed unexpectedly high error fre-
quecies for non-CpG cytosine sites, which were expected
to be occupied by unmethylated cytosines. C!T errors
were observed at 0.89% (10 of 1120; 0.42–1.5%) and
0.96% (11 of 1140; 0.48–1.6%) of cytosine positions in
sequences from untreated and NaOH-treated oligonucleo-
tides, respectively. C!T error frequencies for pooled
data from these two data sets (21 of 2320; 0.91%;
CI¼0.56–1.3%) diﬀer signiﬁcantly from the C!T error
frequency (21 of 8664; 0.24%; 0.15–0.35% observed for
non-CpG cytosines in PCR products from the FMR1
locus in genomic DNA (P¼3.11 10
 5, data not
shown). We have no information that explains why the
C!T error frequency is high for unmethylated cytosines
in our oligonucleotides compared to those in genomic
DNA. Whatever its cause, an error frequency of this
magnitude will have a relatively minor impact on our
estimates of the failed-conversion frequency.
Errors introduced by incomplete deprotection of
5-methylcytosine after olignucleotide synthesis. We inves-
tigated whether apparent inappropriate-conversion events
could have arisen through the sodium hydroxide (NaOH)
treatment that is used to denature DNA prior to bisulﬁte
treatment and/or during the NaOH treatment used to
desulfonate DNA after bisulﬁte treatment.
Our concern about the potential impact of NaOH on
the apparent inappropriate-conversion frequency arose
from details of oligonucleotide synthesis. During the
synthesis of oligonucleotides, isobutyrl-methylcytosines,
rather than 5-methylcytosines, are incorporated at
5-methylcytosine positions. Newly synthesized oligonu-
cleotides are subjected to high-temperature ammonium
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group with an amino group, yielding 5-methylcytosine
(22). Any isobutyrl-methylcytosines that failed to be
deprotected in ammonium hydroxide would remain as
isobutyrl-methylcytosines, rather than the intended
5-methylcytosines. Exposure of any remaining isobutyrl-
methylcytosines to the NaOH before or after bisulﬁte
treatment would likely replace the isobutyrl-amine group
of isobutyrlmethylcytosine with oxygen, rather than the
amino group expected under NH4OH treatment, yielding
thymine rather than 5-methylcytosine, and mimicking
inappropriate conversion.
To investigate the potential impact of failed deprotec-
tion on our error-rate estimates, we treated single-
stranded oligonucleotides with 0.33NNaOH for
30min at 428C, and sequenced subclones. Of the 600
5-methylcytosine positions examined, 599 appeared to
contain cytosine, and one appeared to contain thymine
(Table 2). Thus, we can conclude that errors arising
during NaOH treatment of the oligonucleotide could
yield apparent inappropriate-conversion events at not
more than 0.78% of 5-methylcytosine positions.
Total contribution of bisulfite-independent phenomena to
the frequency of apparent inappropriate-conversion
events. The results described above indicate that no
single bisulﬁte-independent phenomenon made a large
contribution to the apparent inappropriate-conversion
frequency. However, they do not exclude the possibility
that small contributions from several diﬀerent bisulﬁte-
independent phenomena sum to make a substantial
contribution. To address this possibility, we calculated
an upper bound on the overall frequency of bisulﬁte-
independent errors that would mimic inappropriate
conversion.
The value of this upperbound is available from
sequences collected from NaOH-treated oligonucleotides.
Those molecules contain any errors that arose not only
during NaOH-treatment, but also during oligonucleotide
synthesis, and during subsequent PCR ampliﬁcation. Our
ﬁnding that the NaOH-treated molecules were observed to
have 5-methylcytosine at 599 of the 600 expected positions
thus excludes a combined synthesis-, deprotection- and
PCR-error frequency of >0.78% .
We applied the above estimate of the bisulﬁte-
independent error frequency in our analysis of data from
each bisulﬁte treatment protocol, using the approach
described in ‘Methods’ section. This approach allows
us essentially to ‘correct for’ bisulﬁte-independent error,
and thus to estimate the inappropriate-conversion fre-
quency for each treatment duration.
Investigating bisulfite-conversion error by analysis
ofindividual molecules
Published analyses by our group (15,24) and others for
instance (23) have typically excluded individual molecules
that have large numbers of conversion failures, with the
goal of reducing the number of unmethylated cytosines
misinterpreted to be methylated. Here, we consider the
possibility that all molecules, including these typically
excluded ones, can provide useful information relevant to
the dynamics of bisulﬁte-conversion error. Therefore, we
examined both population-mean and single-molecule error
frequencies for single-stranded and hairpin-linked mole-
cules treated under the LowMT and HighMT conditions.
Single-stranded DNA treated under the HighMT
protocol. We measured conversion-error frequencies for
end-coded, single-stranded molecules subjected to
HighMT bisulﬁte for treatment durations ranging from
5 to 200 min. We anticipated, based on the work of
Shiraishi and Hayatsu (16), that 200min of HighMT bisul-
ﬁte treatment would be in excess of the time required to
achieve complete or near-complete conversion of unmethy-
lated cytosines. We hypothesized that inappropriate-
conversion events accrue during prolonged treatment of
molecules that have already achieved complete or near-
complete conversion, and examined individual molecules
to test this possibility.
Our results conﬁrm the ﬁnding of Shirashi and Hayatsu
(16) that the conversion of unmethylated cytosines in
single-stranded DNA occurs very rapidly under HighMT
treatment. We found that 92.6% (100 7.4) conversion of
unmethylated cytosines was achieved after only 30min
of treatment (Table 3). At 80 and 200min, conversion
of unmethylated cytosines was complete (980 of 980
total unmethylated cytosines; 100%, CI¼99.7–100%)
(Figure 4d and e). This indicated that the ﬁnal 120min
of exposure were unnecessary.
We reasoned that if inappropriate-conversion events
occur predominantly on molecules that have already
achieved complete conversion, then the inappropriate-
conversion frequency from the 200min treatment should
be disproportionately greater than the frequencies
observed under shorter treatments. For treatments up to
and including 80min, inferred inappropriate-conversion
frequencies ranged from 0.09% to 1.2% (Table 3), with
no clear relationship between failed- and inappropriate-
conversion counts for individual molecules (Figure 4f–i).
The total number of apparent inappropriate-conversion
events in samples taken at up to 80 min was small
(7 of 1190; 0.42%, CI¼0–0.82%, Table 3). By 200min,
however, the inappropriate-conversion frequency had
reached 6.1% (17 of 270; CI¼3.7–9.9%), and diﬀered
signiﬁcantly from the frequency observed for the earlier
samples (P¼2.2 10
 8). We conclude that bona ﬁde
inappropriate-conversion events occur rarely—if at all—
on our single-stranded oligonucleotide when treated with
HighMT bisulﬁte for up to and including 80min.
These data are consistent with our hypothesis that the
inappropriate-conversion events detected in the 200min
sample occurred primarily during the last 120minutes of
bisulﬁte treatment on molecules that had already achieved
complete conversion.
Single-stranded DNA treated under the LowMT
protocol. We investigated conversion-error frequencies
for single-stranded oligonucleotides subjected to LowMT
conditions for 4h, 8h and 20h. The mean failed-
conversion frequency for the population was 37.3%
after 4h of treatment, and had declined to 6.5% of
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treatments both produced molecules with extremely broad
distributions of failure counts, with SDs of 6.21 and 5.45,
respectively (Figure 5). These were in sharp contrast to
the small SDs (range: 1–2.5; Figure 4) observed for
single-stranded molecules under the HighMT treatment.
In both the 4-h and 8-h samples, a small number of
molecules had already achieved complete conversion.
Nevertheless, in both samples, nearly 60% of molecules
remained unconverted at nearly half of their unmethyl-
ated cytosines (Figure 5a and b). By 20h of treatment,
the distribution of failure counts had shifted markedly
(Figure 5c). Nearly 80% of molecules had achieved
complete conversion, though a small subpopulation of
molecules still had up to 10 unmethylated cytosines that
had not yet been converted. Like single-stranded mole-
cules sampled after short durations of HighMT treatment,
single-stranded molecules sampled after short durations of
LowMT treatment showed no clear relationship between
the failed- and inappropriate-conversion counts on indi-
vidual molecules (Figure 5d and e).
In the previous section describing single-stranded DNA
treated under HighMT conditions, we identiﬁed 80min
as the duration by which most molecules have achieved
complete conversion, and beyond which inappropriate-
conversion events accrue. We therefore sought to identify
Figure 4. Single-stranded oligonucleotides exposed to HighMT bisulﬁte. Distributions of failed-conversion counts for molecules treated in HighMT
bisulﬁte for 5min (a), 15min (b), 30min (c), 80min (d) and 200min (e). We use n to indicate the number of molecules examined; conversion failures
are summarized by the mean number of failed-conversion events per molecule, and the SD on this mean. Sunﬂower plots of individual-molecule
failed- and inappropriate-conversion counts for molecules treated with HighMT bisulﬁte for 5min (f), 15min (g), 30min (h), 80min (i) and
200min (j). A single point indicates one molecule, a line indicates two and a z-petaled ‘ﬂower’ indicates z-molecules.
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similar combination of low frequencies for both failed
and inappropriate conversion on single-stranded DNA.
For the 4-h treatment, the inferred inappropriate-
conversion frequency was 0.31% (1 event out of
210 opportunities; CI¼0–2.6%), indicating that few
inappropriate-conversion events occurred during the
ﬁrst 4-h of treatment. For the 8-h sample, the inferred
inappropriate-conversion frequency was 1.2% (7 events
out of 520 opportunities; CI¼0–2.7%), suggesting that
inappropriate conversion had begun to occur. By 20h,
the inferred inappropriate-conversion frequency had
climbed to 3.1% (19 events out of 580 opportunities;
CI¼1.7–4.8%; Table 4). In this sample, molecules with
no conversion failures had an inappropriate-conversion
frequency of 3.6% (17 of 440; CI¼1–5.2%); mole-
cules with one-or-more conversion failures had an
inappropriate-conversion frequency of 1.2% (2 of 140;
CI¼0.016–3.6%). This diﬀerence was small and did not
lead to statistical signiﬁcance (P¼0.27), but hinted that
the zero-failure molecules had begun to experience
inappropriate conversion.
To further explore this possibility, we pooled data from
the three LowMT treatment durations. In view of our
hypothesis that individual molecules, not populations,
accrue inappropriate-conversion events after attaining
high levels of conversion of their unmethylated cytosines,
and in light of our ﬁnding that single-stranded molecules
were broadly distributed in their times to complete con-
version under the LowMT treatment, we reasoned that
well-converted molecules from all three time samples
might have accrued inappropriate-conversion events.
Combining data from the 4-h, 8-h and 20-h treatments,
we compared inappropriate-conversion event counts on
zero-failure molecules to counts for one-or-more failure
molecules. Inappropriate-conversion counts diﬀered
signiﬁcantly between molecules with zero-failures (20 of
610 opportunities; 3.1%, CI¼1.8–4.6%) and those mole-
cules with one-or-more failures (7 of 700; 0.83%,
CI¼0.23–1.6%, P¼0.006; Figure 5).
Figure 5. Single-stranded oligonucleotides exposed to LowMT bisulﬁte. Distributions of failed-conversion counts for bisulﬁte treatments of 4h (a),
8h(b) and 20h (c). Sunﬂower plots of individual molecule failed- and inappropriate-conversion counts for treatments of 4h (d), 8h (e) and 20h (f).
We use n to indicate the number of molecules examined; conversion failures are summarized by the mean number of failed-conversion events per
molecule and the SD on this mean. A single point indicates one molecule, a line indicates two and a z-petaled ‘ﬂower’ indicates z-molecules.
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ments, when prolonged beyond the time required for
complete or nearly complete conversion, can lead to
unnecessarily large numbers of inappropriate conversion
events on single-stranded molecules. Moreover, under the
LowMT treatment, single-stranded molecules that attain
complete conversion early during bisulﬁte treatment can
begin to accrue inappropriate-conversion events before
conversion is complete for the majority of molecules.
This phenomenon will lead to unnecessarily large
inappropriate-conversion frequencies.
Hairpin-linked DNA treated under HighMT
conditions. We hairpin-linked synthetic oligonucleotides,
(19) and sampled molecules after 40min, 60min and
90min of HighMT bisulﬁte exposure.
Like single-stranded molecules, populations of hairpin-
linked molecules under HighMT conditions exhibited
declining failed-converison counts with increasing treat-
ment duration. Molecules were well-converted after
40min of treatment (2027 out of 2214; 91.6%,
CI¼90.3–92.6%), and almost completely converted
after 90min of treatment (99.14%; 2195 of 2214;
CI¼98.9–99.5%, Table 5). The distributions of per-
molecule failure counts for hairpin-linked molecules
under HighMT treatment had SDs ranging from 0.78 to
2.6 (Figure 6a–c). These SDs are similar to those we
observed for single-stranded DNA under HighMT
Figure 6. Hairpin-linked oligonucleotides exposed to HighMT bisulﬁte. Distributions of failed-conversion counts for bisulﬁte treatments of 40min
(a), 60min (b) and 90min (c). We use n to indicate the number of molecules examined; conversion failures are summarized by the mean number of
failed-conversion events per molecule and the SD on this mean. Sunﬂower plots of individual-molecule failed- and inappropriate-conversion counts
for bisulﬁte treatments of 40min (d), 60min (e) and 90min (f). A single point indicates one molecule, a line indicates two and a z-petaled ‘ﬂower’
indicates z-molecules.
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observed for single-stranded DNA under LowMT treat-
ment. This result suggested that the distribution of failure
counts within a given sample might be determined primar-
ily by the bisulﬁte treatment conditions—that is, HighMT
versus LowMT—rather than by the strandedness of the
DNA.
Together, the 40-, 60- and 90-min samples contained a
total of 30 inappropriate-conversion events out of the
1871 readable 5-methylcytosines examined, yielding
an inferred inappropriate-conversion frequency of 1.4%
(CI¼0.91–2.1%; Table 5), indicating that inappropriate
conversion can occur on hairpin-linked molecules treated
under HighMT conditions.
Hairpin-linked DNA treated under the published hairpin-
bisulfite PCR protocol. We asked whether inappropriate
conversion can also occur during treatment of hairpin-
linked DNA treated under our published hairpin-bisulﬁte
PCR protocol [(15), modiﬁed in (19)], which uses LowMT
conditions, and includes 10 thermal denaturation steps.
We examined 71 encoded, hairpin-linked oligonucleotides
subjected to this treatment.
All of the oligonucleotides treated using our published
protocol had nearly complete conversion of their
unmethylated cytosines (3829 of 3834; 99.87%;
CI¼99.7–99.9%). The distributions of per-molecule
failure counts were extremely narrow: only ﬁve molecules
had any failed conversions, and no molecule had more
than one (Figure 7). Of the 1368 5-methylcytosine sites
that could be read unambiguously from eletropherograms
for these molecules, 50 appeared as thymine, yielding
an inferred inappropriate-conversion frequency of 3.5%
(CI¼2.7–4.9%).
Most of the molecules collected under the published
hairpin-bisulﬁte PCR protocol were completely converted
(Figure 7). Thus, it seemed possible that many or all of
these molecules had been treated beyond the point neces-
sary to achieve complete or near-complete conversion, and
that most or all of the inappropriate-conversion events
occurred on molecules that had already achieved complete
conversion. The small number of molecules with one-
or-more failures prohibited a statistical examination of
this possibility.
Indeed, the inappropriate-conversion frequency was
higher for the molecules with no conversions failures
(48 of 1268 5-methylcytosine positions examined), than
for the molecules that had one conversion failure (2 of
100 examined), but this result did not reach statistical
signiﬁcance (P¼0.58).
Site-site variation inconversion-error frequencies
One advantage of investigating conversion errors on valid-
ated, individual molecules is the opportunity to measure
site-speciﬁc error frequencies. Harrison et al. (25) noted
that the conversion rate for a given cytosine can depend
on its sequence context. Here, we examined our data from
validated single-stranded oligonucleotides to investigate
whether or not failed-conversion frequencies diﬀered
among the sites on our single-stranded molecules and
Figure 7. Hairpin-linked DNA treated under the published hairpin-bisulﬁte PCR protocol. (a) Distribution of failed-conversion counts. We use n to
indicate the number of molecules examined; conversion failures are summarized by the mean number of failed-conversion events per molecule and
the SD on this mean. (b) Sunﬂower plot of individual-molecule failed- and inappropriate-conversion counts. A single point indicates one molecule,
a line indicates two and a z-petaled ‘ﬂower’ indicates z-molecules.
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HighMT treatments.
Site–site variation in failed-conversion frequencies. The
LowMT treatment yielded signiﬁcant heterogeneity in
site-speciﬁc failed-conversion counts for the 4h
(P¼0.0045), 8h (P¼0.00045) and 20h (P¼0.007) time
points (Figure 8a–c). These results conﬁrm the ﬁnding of
Harrison et al. (25) that individual sites can diﬀer in their
conversion rates when exposed to conditions similar to the
LowMT conditions reported here.
Two of the more rapidly converted sites, 1 and 2, had
attained nearly complete conversion by 4h of treatment
(Figure 8d). In contrast, two of the more slowly
converted sites, 7 and 9, remained poorly converted at
8h. Even by 20h, one of these—site 9—had yet to be
converted in 10 of 58 (16%) of sequences (Figure 8c
and d). Although it seems likely that prolonged treatment
would reduce the frequency of failed-conversions at these
more slowly converted sites, such prolonged treatment
would likely also further increase the inappropriate-
conversion frequency, which, by 20h, had already reached
3.1% (Table 4). Multiple thermal-denaturation steps
would likely reduce the site–site heterogeneity observed
after LowMT treatment for 20h. We have not, however,
systematically explored this possibility.
The HighMT treatment, as compared to the LowMT
treatment, yielded remarkably little variation among sites
in the time to complete conversion (Figure 9). Although
sites diﬀered somewhat in their frequencies of conversion
when examined early in the treatment, by 30min, sampled
molecules contained no evidence of site-site variation in
failed-conversion counts (P¼0.15). The time course of
conversion observed was similar for sites 1 and 2, which
were converted fairly rapidly, and sites 7 and 9, which
were comparatively slow in their conversion (Figure 9d).
We conclude that the HighMT treatment, compared to
the LowMT treatment, yields substantially less site–site
heterogeneity in the time to complete conversion of
unmethylated cytosines.
Site–site variation in inappropriate-conversion
frequencies. We summed site-speciﬁc inappropriate-
conversion counts across all treatment durations and
Figure 8. Single-stranded DNA treated under LowMT conditions. Cytosine site-speciﬁc failed-conversion counts for LowMT-treated, single-stranded
DNA examined after 4h (a), 8h (b) and 20h (c). Fraction of unmethylated cytosines surviving at two relatively rapidly converted sites (1 and 2) and
two relatively slowly converted sites (7 and 9) after treatment for 4 to 20h (d). The ‘N’ indicates the total number of molecules examined.
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frequency of inappropriate-conversion diﬀered across
5-methylcytosine sites. We found no evidence of signiﬁ-
cant site–site variation under either the HighMT treat-
ment (P¼0.995; Figure 10a), or the LowMT treatment
(P¼0.86; Figure 10b).
Our power to detect diﬀerences among sites was
much lower for inappropriate conversion than for failed
conversion because these events were less common, and
because each sequence contained fewer sites informative
about inappropriate conversion (10 for inappropriate
conversion versus 19 for failed conversion). Even so,
site–site variation in inappropriate-conversion frequencies
appeared to be small. Thus, under protocols that yield low
inappropriate-conversion frequencies, the impact of site–
site variation on data analysis is likely to be negligible.
Conversiondynamics andthe design of
bisulfite-treatment protocols
Choosing bisulfite-conversion conditions. Shiraishi and
Hayatsu (16) recommended HighMT treatment as a way
to accelerate the bisulﬁte-conversion process, and to
reduce inappropriate-conversion frequencies, while still
achieving good conversion of unmethylated cytosines.
We have conﬁrmed with validated data collected from
synthetic oligonucleotides that the HighMT treatment
can indeed yield samples with low mean frequencies of
both failed and inappropriate conversion.
Our investigation of errors on individual molecules and
at individual sites revealed an additional and unanti-
cipated advantage of the HighMT compared to the
LowMT treatment: the HighMT method produces mark-
edly less variation among molecules and among sites in
the time to complete conversion. This diﬀerence between
the LowMT and HighMT treatments is highly relevant in
Figure 9. Single-stranded DNA treated under HighMT conditions. Cytosine site-speciﬁc failed-conversion counts for HighMT-treated, single-stranded
DNA examined after 5min (a), 15min (b) and 30min (c). Fraction of unmethylated cytosines surviving at two relatively rapidly converted sites
(1 and 2), and two relatively slowly converted sites (7 and 9) after treatment for 5–200min (d). We use n to indicate the total number of sequences
examined.
Figure 10. Inappropriate-conversion counts at 5-methylcytosine sites in
single-stranded DNA. End-coded single-stranded oligonucleotides were
treated with bisulﬁte under HighMT (a), and LowMT (b) conditions.
The inappropriate-conversion count for each site is the sum of events
across all treatment durations for which data are reported in Tables 3
and 4, respectively.
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accumulate predominantly on molecules that have already
attained complete or near-complete conversion. Under
the LowMT method, prolonged treatment is necessary
to attain high levels of conversion for all sites and all
molecules. Such prolonged treatment has the disadvantage
of subjecting molecules in the well-converted subpopula-
tion to increased numbers of inappropriate-conversion
events.
Modulating bisulfite-conversion error frequencies to
address a specific biological question. Our results from
both single-stranded and hairpin-linked DNA suggest
that HighMT treatment yields low—but non-zero—
frequencies of conversion error. By examining the rela-
tionship between failed- and inappropriate-conversion
frequencies, it should be possible to optimize treatment
duration to suit a speciﬁc biological question.
For experiments where even a very small number of
methylated cytosines would provide important biological
information, it will be desirable to minimize the misclassi-
ﬁcation of unmethylated cytosines as methylated. For
instance, it remains uncertain whether or not there is a
low level of non-CpG methylation in mammalian somatic
or embryonic stem cells (26) and whether or not CpG
methylation occasionally occurs in the promoters of
genes on the active X chromosome of human females.
To collect data useful to address these issues, it is desirable
to choose a protocol and treatment duration with a low
failure frequency, and to tolerate the concomitantly
high inappropriate-conversion frequency. Our analysis of
failed- and inappropriate-conversion frequencies suggests
that HighMT treatment at durations that yield >99.9%
conversion of unmethylated cytosines will meet this goal
(Figure 11).
For experiments where even a very small number of
unmethylated cytosines would provide important biologi-
cal information, it will generally be desirable to minimize
the number of inappropriate-conversion events. Some cell
lines have been reported to have nearly complete DNA
methylation at some loci (16). These ﬁndings are in
contrast to data from human somatic cells, which do
not indicate comparably high densities in methylated
regions (15). To assess whether complete or near-complete
methylation really does occurs in some biological cases,
or whether it is instead an artifact of conversion error,
it is necessary to choose conditions that yield low
inappropriate-conversion frequencies. For this goal, too,
HighMT conditions seem preferable. Speciﬁcally, our data
indicate that for our single-stranded oligonucleotide
treated under HighMT conditions, durations of
 50–80min would yield successful conversion frequencies
between 98% and 99.9%, with few or no inappropriate-
conversion events. From Shiraishi and Hayatsu’s (16)
work with plasmid DNA, we predict that a HighMT treat-
ment duration of 20 to 30min would yield a comparable
pair of failed- and inappropriate-conversion frequencies.
Below, we discuss some parameters that may contribute
to variation among DNAs of interest in the treatment
duration required to achieve a given level of conversion.
HighMT treatment is surprisingly robust to differences in
sequence concentration, complexity and secondary struc-
ture of the target DNA. Previous ﬁndings indicate that
bisulﬁte conversion is most eﬃcient for unpaired cytosines
(11). Protocols for conversion of single-copy loci in
genomic DNA typically achieve this unpairing with a
NaOH denaturation step prior to bisulﬁte treatment.
Under the LowMT protocol, this initial NaOH treatment
seems insuﬃcient to yield high levels of conversion for all
molecules; at least one thermal-denaturation step is often
included in pursuit of this goal. We are not aware of a
detailed study of how the importance of thermal denatura-
tion varies among target loci. It seems likely that DNA
concentration and sequence complexity, GC content, and
the presence or absence of a hairpin linker are key param-
eters. These parameters will inﬂuence the rate at which
complementary strands renature after NaOH treatment,
and, in particular, the extent to which cytosines remain
unpaired upon introduction of bisulﬁte, and thus available
for eﬃcient conversion.
When genomic DNA is subjected to NaOH treatment,
complementary strands are denatured, and diﬀuse away
from one another. It is unlikely that complementary
strands of single-copy loci in mammalian genomes will
meet and renature during the subsequent bisulﬁte treat-
ment. For repetitive elements, the renaturation rate
is markedly higher (27) than for single-copy loci, so it is
possible that they at least partially renature during
bisulﬁte treatment, potentially slowing the conversion
process (14). It seems likely that the one or more thermal
denaturation steps often used with conventional bisulﬁte
Figure 11. Inferred time courses of conversion of cytosine, and
inappropriate conversion of 5-methylcytosine, in single-stranded DNA
under HighMT bisulﬁte conditions. For each treatment duration
examined, we indicate the fractions of surviving 5-methylcytosines
(squares) and cytosines (diamonds), as given in Table 3. Error bars
show 95% intervals for these point estimates (see Methods section).
Vertical dashed lines indicate the treatment durations inferred as
suﬃcient to achieve 99%, 99.5% and 99.9% conversion of cytosines,
as extrapolated from the best-ﬁt curve. To determine the relationship
of the inappropriate-conversion frequency to treatment duration, we
inferred the best ﬁt line from all six time points, including the 0 time
point. This line indicated a signiﬁcant relationship between treatment
duration and inappropriate-conversion frequency (P¼0.0076). As des-
cribed in the text, this signiﬁcant relationship was driven entirely by
data from the 200min sample. When we excluded this 200min sample
from the analysis (uppermost line, truncated at 80min), there was no
evidence of a signiﬁcant relationship.
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successively denaturing DNA, until further renaturation
is disfavored by the reductions in complementarity that
accrue through conversion of unmethylated cytosines
to uracils.
Because thermal-denaturation steps are absent from the
HighMT protocol, we were especially surprised by two of
our ﬁndings under this treatment. First, the rate of con-
version under HighMT conditions diﬀered by a factor of
only 2 between our highly concentrated, single-stranded
oligonucleotide and the less-concentrated and larger,
more complex plasmid examined by Shiraishi and
Hayatsu (16) (Figure 12). If renaturation were impeding
the conversion process in proportion to the sequence com-
plexity and the concentration of the target DNA, the
initial conversion rates for these two DNAs would diﬀer
by several orders of magnitude, rather than by a factor of
only 2. Second, the rate of conversion under HighMT
conditions was greater by only a factor of 1.5 for our
single-stranded olignucleotide, compared to our hairpin-
linked oligonucleotide. This is surprising in that the
hairpin-linked molecule is expected to ‘snap back’ to its
double-stranded state immediately upon removal from
denaturing conditions, thus impairing conversion until
there is substantial loss of complementarity. These two
results suggest that HighMT conditions lead to partial
or complete DNA denaturation, and/or that bisulﬁte
conversion under HighMT conditions can occur on
paired cytosines. Our data do not allow us to distinguish
between these two possibilities.
Initial results indicate that eukaryotic genomic DNAs,
like the prokaryotic DNA described by Shiraishi and
Hayatsu (16) and the synthetic DNA described here,
undergo rapid conversion under HighMT conditions.
Shiraishi and Hayatsu (16) applied HighMT treatment
to human genomic DNA, and achieved >99% conversion
by 40 min. We have conﬁrmed this ﬁnding, and extended
it to the FMR1 promoter region in hairpin-linked genomic
DNAs that were encoded with batch-stamps and bar-
codes. We examined the conversion dynamics of DNA
puriﬁed from a lymphoblastoid cell line established using
cells from a male aﬀected with fragile X syndrome
(GM03200A; Coriell). Non-CpG cytosines in the
examined region of the FMR1 locus in this genomic
DNA had a time course of conversion under HighMT
treatment that was similar to that reported above for
hairpin-linked oligonucleotides (Figure 12), with 99.5%
conversion achieved by 80min of treatment.
Proteinase K digestion was a step in the isolation
procedure for the genomic DNAs reported on here and
in Shirashi and Hayatsu (16). Such proteinase digestion
has been recommended by Warnecke et al. (28) as a means
to reduce conversion-rate variation that may arise if pro-
teins remain bound to puriﬁed DNA. We have not inves-
tigated, and Shiraishi and Hayatsu (16) did not report on,
whether conversion rates under HighMT conditions diﬀer
among genomic DNAs isolated under diﬀerent protocols.
These are important variables to investigate in future
work applying HighMT treatment to genomic DNAs.
Regardless of the results of these investigations, it is
clear that genomic DNA subjected to HighMT treatment
can undergo rapid conversion in both single-stranded and
hairpin-linked conﬁgurations.
The ability of HighMT conditions rapidly to convert
genomic and synthetic DNAs that are both hairpin-
linked and GC rich suggests that most DNAs may be
amenable to rapid conversion under this protocol. The
durations of HighMT treatment required for conversion
of a broad range of target loci at various DNA concentra-
tions likely span a narrow range—possibly <2hours
(Figure 12).
Conversion error as information
Methylation patterns, particularly those on densely
methylated molecules, often vary substantially within
populations of cells. PCR ampliﬁcation sometimes fails
to capture this epigenetic diversity, yielding data sets
composed mostly or exclusively of multiple sequences
that are derived from a single template molecule. Using
molecular-encoding techniques, we have identiﬁed the two
phenomena that are principally responsible for the lack
of pattern diversity in these data sets. One of these, tem-
plate redundancy, occurs when the products of a given
PCR ampliﬁcation are dominated by the amplimers of a
single genomic template from the intended experiment.
The other, PCR contamination, occurs when an ampliﬁ-
cation reaction is contaminated, and sometimes even
dominated, by copies of one or a few amplimers from
a previous reaction (19). We have applied molecular-
encoding techniques to single-stranded DNA, as described
here (Methods section), and more fully elsewhere (Burden
et al., manuscript in preparation).
For methylation data gathered in the absence of molec-
ular encoding, it has typically been diﬃcult to distinguish
Figure 12. Comparison of conversion rates for unmethylated cytosines
in plasmid DNA, singlestranded oligonucleotides and hairpin-linked
oligonucleotides. Failed-conversion rate data are compared here for
end-coded, single-stranded oligonucleotides (Table 3), hairpin-linked
oligonucleotides (Table 5), and for plasmid DNA [from Figure 2 of
Shiraishi and Hayatsu (16)]. Data were log-transformed and best-
ﬁt lines estimated as described in Methods section. Solid lines indicate
treatment durations bounded by recorded data; dashed lines indicate
extrapolations from recorded data.
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dancy and contamination. Conversion errors can some-
times help to ﬁll this void insofar as they independently
mark individual genomic template molecules, and thus
can alert experimenters to likely contamination and
redundancy. This insight was recently applied to methyla-
tion patterns collected from the leptin promoter in sperm
DNA from mouse (24).
The expected methylation features of the DNA of
interest determine whether failed- or inappropriate-
conversion events will be informative about possible
contamination and redundancy. In experiments with
mammalian somatic DNA, failed-conversion events will
be of greater utility. In these DNAs, methylation is
expected to occur mostly or exclusively at CpG cytosines.
Thus, any non-CpG cytosines that appear as cytosines in
resulting sequence data almost certainly result from failed-
conversion, rather than from bona ﬁde methylation.
When failed-conversion events occur, they happen prior
to PCR ampliﬁcation on individual genomic template
molecules. Consequently, when the same pattern of
failed-conversion events appears on two or more mole-
cules, PCR redundancy—rather than biological
identity—is most likely the cause.
We illustrate this point with six sequences collected
through PCR ampliﬁcation of end-coded oligonucleotides.
Like mammalian DNA, these oligonucleotides have
methyl groups at cytosines within CpG dinucleotides,
but not on other cytosines. As we describe in previous
sections, these molecules were ﬁrst encoded with a molec-
ular batchstamp, and a set of random barcodes, and then
subjected to bisulﬁte conversion (Figure 13). The three
sequences in Figure 13a all contain the same, intended
batch-stamp, indicating that they are not contaminants.
However, these three sequences bear an identical barcode,
indicating that they are almost certainly copies of a
single template molecule. Their identical patterns of
failed-conversion events are consistent with the informa-
tion from their molecular codes, and indicate that these
sequences are clones of one another, and should be con-
sidered as one molecule—not three—in the analysis of
these data.
In contrast, the three sequences in Figure 13b are
unique, valid sequences. Each of them bears the expected
batch-stamp, indicating that each is from the intended
experiment. Each sequence also has a barcode diﬀerent
from the barcode on the other two sequences, indicating
that each arose from a diﬀerent template molecule. These
sequences also diﬀer in their patterns of unconverted
non-CpG cytosines, suggesting that each is the product
of a template molecule that proceeded independently
through the bisulﬁte-conversion process. Thus informa-
tion available from the conversion errors on these mole-
cules conﬁrms the information available from their
molecular codes.
Conversion error as a surrogate for molecular encoding
is, of course, useful only when errors occur at detectable
frequencies. Whether or not this condition is met during
a given bisulﬁte conversion depends on the error frequen-
cies themselves, and on the number of opportunities
for error. In some circumstances, it may be desirable to
choose conversion conditions that give rise to error fre-
quencies that are suﬃcient to authenticate resulting
sequence data.
CONCLUDING REMARKS
Shiraishi and Hayatsu (16) introduced the HighMT
bisulﬁte-conversion protocol to reduce the time required
to collect reliable data on DNA methylation. We evalu-
ated conversion rates for LowMT and HighMT treatment
of synthetic oligonucleotides, whose deﬁned methylation
patterns enabled us to examine conversion errors without
confounding by the biological variation that is typical of
Figure 13. Conversion errors can distinguish between clonal and unique sequences. (a) Three clonal sequences from end-coded, single-stranded
oligonucleotides (Burden et al., manuscript in preparation). All three sequences bear the expected GTATGTGT batchstamp, indicating that they are
from the intended experiment. However, they have the same barcode, TTAGATA, indicating that they are clones. Their shared pattern of failed-
conversion events conﬁrms their common origin from a single template molecule. (b) Three unique sequences from end-coded, single-stranded
oligonucleotides. Each sequence bears the GTATGTGT batchstamp (bold-faced) used in this experiment, and a unique barcode. These sequences
also diﬀer in their patterns of failed-conversion events (dark gray boxes), conﬁrming that they proceeded through the conversion and ampliﬁcation
processes independently.
PAGE 17 OF19 Nucleic Acids Research, 2008, Vol. 36,No. 22 e150genomic DNA (24). Our examination of these bisulﬁte-
treated molecules, validated with molecular encoding,
revealed an additional and unexpected beneﬁt of this
new protocol: a marked reduction in heterogeneity
among sites and among molecules in the time to complete
conversion of unmethylated cytosines.
Our ﬁndings indicate that:
(i) Inappropriate-conversion events can occur under
both HighMT and LowMT treatments;
(ii) 5-methylcytosines are largely refractory to
inappropriate conversion early in bisulﬁte treatment,
and become vulnerable principally when molecules
are exposed to bisulﬁte beyond the time when they
achieve complete or near-complete conversion of
their unmethylated cytosines. This ﬁnding highlights
the importance of modulating bisulﬁte-conversion
protocols so that treatment duration does not
exceed the time to complete or near-complete con-
version for the majority of molecules;
(iii) The HighMT protocol is preferable to the LowMT
protocol because it decreases the treatment duration
required to achieve a given level of conversion and
because it yields greater homogeneity across both
molecules and sites in the time course of conversion.
This greater homogeneity reduces the risk that sub-
populations of molecules, and individual sites, will
attain complete conversion early during the treat-
ment, and then accrue inappropriate-conversion
events before conversion is complete for other mole-
cules and sites. One potential explanation for this
greater homogeneity is that the HighMT treatment
fosters partial or complete denaturation of DNA,
thereby reducing diﬀerences among regions in the
time spent in the single-stranded state that is suscep-
tible to conversion;
(iv) For some analyses of bisulﬁte-treated DNA, the value
of complete conversion of unmethylated cytosines is
great, and may warrant attendant increases in the
frequency of inappropriate conversion. For other
applications, low frequencies of inappropriate con-
version will be essential to reliable data. Shiraishi
and Hayatsu’s (16) HighMT protocol provides a
valuable opportunity for ﬁne-scale modulation of
error frequencies to achieve the balance of failed
and inappropriate-conversion events that is best-
suited to address a speciﬁc biological question; and
(v) Even the HighMT protocol will rarely yield data sets
that contain no conversion errors at all. Conversion
errors introduce apparent diversity among DNA
methylation patterns, so recovery of large numbers
of sequences with identical methylation patterns
strongly suggests the occurrence of PCR contamina-
tion and/or redundancy. Conversion errors thus can
be used to assess the validity of data sets collected
without the beneﬁt of molecular encoding.
We recommend that the HighMT protocol be used to
improve both the eﬃciency and the reliability of bisulﬁte
treatments used to collect epigenetic data.
ACKNOWLEDGEMENTS
We thank Audrey Fu, Stanley Gartler, Bruce Godfrey,
Scott Hansen and Matthew Stephens for their many help-
ful suggestions; the developers of the bisulﬁte-treatment
protocols evaluated here, especially Marianne Frommer,
Susan Clark and Hikoya Hayatsu, for their encour-
agement and input over many years; and Ali Javed of
GeneLink for providing detailed information on oli-
gonucleotide synthesis and the purity of isobutyrl-
methylcytosine stocks.
FUNDING
National Institutes of Health (HD002274, GM077464 to
C.D.L.); T32 HG00035 Training Grant (to the University
of Washington). Funding for open access charge: NIH
(HD002274 and GM077464).
Conﬂict of interest statement. None declared.
REFERENCES
1. Sto ¨ ger,R., Kubicka,P., Liu,C.G., Kafri,T., Razin,A., Cedar,H. and
Barlow,D.P. (1993) Maternal-speciﬁc methylation of the imprinted
mouse Igf2r locus identies the expressed locus as carrying the
imprinting signal. Cell, 73, 61–71.
2. Swain,J.L., Stewart,T.A. and Leder,P. (1987) Parental legacy
determines methylation and expression of an autosomal transgene: a
molecular mechanism for parental imprinting. Cell, 50, 719–727.
3. Feinberg,A.P. and Vogelstein,B. (1987) Alterations in DNA
methylation in human colon neoplasia. Semin. Surg. Oncol., 3,
149–151.
4. Laird,C.D., Jaﬀe,E., Karpen,G., Lamb,M. and Nelson,R. (1987)
Fragile sites in human chromosomes as regions of late-replicating
DNA. Trends Genet., 3, 274–281.
5. Jacobsen,S.E. and Meyerowitz,E.M. (1997) Hypermethylated
SUPERMAN epigenetic alleles in Arabidopsis. Science, 277,
1100–1103.
6. Cubas,P., Vincent,C. and Coen,E. (1999) An epigenetic mutation
responsible for natural variation in oral symmetry. Nature, 401,
157–161.
7. Frommer,M., McDonald,L.E., Millar,D.S., Collis,C.M., Watt,F.,
Grigg,G.W., Molloy,P.L. and Paul,C.L (1992) A genomic
sequencing protocol that yields a positive display of
5-methylcytosine residues in individual DNA strands. Proc. Natl
Acad. Sci. USA, 89, 1827–1831.
8. Clark,S.J., Harrison,J. and Frommer,M. (1995) CpNpG methyla-
tion in mammalian cells. Nat. Genet., 10, 20–27.
9. Sto ¨ ger,R., Kajimura,T.M., Brown,W.T. and Laird,C.D. (1997)
Epigenetic variation illustrated by DNA methylation patterns of the
fragile-X gene FMR1. Hum. Mol. Genet., 6, 1791–1801.
10. Genereux,D.P., Miner,B.E., Bergstrom,C.T. and Laird,C.D. (2005)
A population-epigenetic model to infer site-specic methylation rates
from double-stranded DNA methylation patterns. Proc. Natl Acad.
Sci. USA, 102, 5802–5807.
11. Frommer,M., McDonald,L.E., Millar,D.S., Collis,C.M., Watt,F.,
Grigg,G.W., Molloy,P.L. and Paul,C.L. (1992) A genomic sequencing
protocol that yields a positive display of 5-methylcytosine residues in
individual DNA strands. Proc. Natl Acad. Sci. USA, 89, 1827–1831.
12. Clark,S.J., Harrison,J., Paul,C.L. and Frommer,M. (1994) High
sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22,
2990–2997.
13. Bird,A. (1992) The essentials of DNA methylation. Cell, 70, 5–8.
14. Grunau,C., Clark,S.J. and Rosenthal,A. (2001) Bisulﬁte genomic
sequencing: systematic investigation of critical experimental
parameters. Nucleic Acids Res., 29, e65
15. Laird,C.D., Pleasant,N.D., Clark,A.D., Sneeden,J.L.,
Hassan,K.M.A., Manley,N.C., VaryJr,J.C., Morgan,T.,
e150 Nucleic Acids Research, 2008, Vol. 36, No. 22 PAGE 18 OF19Hansen,R.S. and Sto ¨ ger,R. (2004) Hairpin-bisulte PCR: assessing
epigenetic methylation patterns on complementary strands of indi-
vidual DNA molecules. Proc. Natl Acad. Sci. USA, 101, 204–209.
16. Shiraishi,M. and Hayatsu,H. (2004) High-speed conversion of
cytosine to uracil in bisulﬁte genomic sequencing analysis of
DNA methylation. DNA Res., 11, 409–415.
17. Hayatsu,H., Tsuji,K. and Negishi,K. (2006) Does urea promote the
bisulﬁte-mediated deamination of cytosine in DNA? Investigation
aiming at speeding-up the procedure for DNA methylation analysis.
Nucleic Acids Symp. Ser., 50, 69–70.
18. Egger,G., Jeong,S., Escobar,S.G., Cortez,C.C., Li,T.H., Saito,Y.,
Yoo,C.B., Jones,P.A. and Liang,G. (2006) Identication of DNMT1
(DNA methyltransferase 1) hypomorphs in somatic knockouts
suggests an essential role for DNMT1 in cell survival. Proc.
Natl Acad. Sci. USA, 103, 14080–14085.
19. Miner,B.E., Sto ¨ ger,R.J., Burden,A.F., Laird,C.D. and Hansen,R.S.
(2004) Molecular barcodes detect redundancy and contamination in
hairpin-bisulte PCR. Nucleic Acids Res, 32, e135.
20. Chertkov,B.A., Pankratova,V.N. and Dobromyslova,N.S. (1973)
Spontaneous decomposition of concentrated ammonium
sulﬁte-bisulﬁte solutions. Sov. Chem. Ind., 49, 383–387.
21. LaPlace,P.S. (1814) (trans. by Truscott,F.W. and Emory,F.L., 1951)
A Philosophical Essay on Probabilities (1951 edn) Dover, New York.
22. Schulhof,J.C., Molko,D. and Teoule,R. (1987) The ﬁnal deprotection
step in oligonucleotide synthesis is reduced to a mild and rapid
ammonia treatment by using labile base-protecting groups. Nucleic
Acids Res., 15, 397–416.
23. Nishiyama,R., Qi,L., Lacey,M. and Ehrlich,M. (2005) Both hypo-
methylation and hypermethylation in a 0.2-kb region of a DNA
repeat in cancer. Mol. Cancer Res., 3, 617–626.
24. Sto ¨ ger,R. (2006) In vivo methylation patterns of the leptin promoter
in human and mouse. Epigenetics, 1, 155–162.
25. Harrison,J., Stirzaker,C. and Clark,S.J. (1998) Cytosines adjacent to
methylated CpG sites can be partially resistant to conversion in
genomic bisulﬁte sequencing leading to methylation artifacts.
Ann. Biochem, 264, 129–132.
26. Ramsahoye,B.H., Biniszkiewicz,D., Lyko,F., Clark,V.,
Bird,A.P. and Jaenisch,R. (2000) Non-CpG methylation is
prevalent in embryonic stem cells and may be mediated by
DNA methyltransferase 3a. Proc. Natl Acad. Sci. USA, 97,
5237–5242.
27. Britten,R.J. and Kohne,D.E. (1968) Repeated sequences in DNA.
Science, 161, 529–540.
28. Warnecke,P.M., Stirzaker,C., Song,J., Grunau,C., Melki,J.R. and
Clark,S.J. (2002) Identication and resolution of artifacts in bisulte
sequencing. Methods, 27, 101–107.
PAGE 19 OF19 Nucleic Acids Research, 2008, Vol. 36,No. 22 e150